
HIMS Stock Forecast & Price Target
HIMS Analyst Ratings
Bulls say
Hims & Hers Health Inc demonstrated significant financial growth, achieving a total revenue increase of 95.1% year-over-year, with online revenue surging 98.3% to $470.8 million, exceeding expectations. The company also experienced substantial subscriber growth, adding 182,000 new subscribers in the quarter to reach 2.2 million, reflecting a 45% increase year-over-year. Furthermore, the shift towards personalized offerings has been notable, with 55.9% of subscribers now utilizing such services, contributing to a strong operational performance characterized by a robust combination of growth and profitability.
Bears say
Hims & Hers Health has expressed concerns regarding high prices in the healthcare market, which could hinder its ability to compete effectively against venture-backed companies that can undercut pricing to capture market share, potentially threatening customer retention and profitability. In addition, a reduction in gross margins due to pricing adjustments for GLP-1 drugs and rising costs could further pressure operating margins, which were reported at 8.9%, falling short of estimates. The company's elevated valuation, trading at over 4x EV/Sales, coupled with these financial challenges, raises significant concerns regarding its future performance.
This aggregate rating is based on analysts' research of Hims & Hers Health and is not a guaranteed prediction by Public.com or investment advice.
HIMS Analyst Forecast & Price Prediction
Start investing in HIMS
Order type
Buy in
Order amount
Est. shares
0 shares